New York, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Chronic Myelomonocytic Leukemia (CMML) Clinical Trial Analysis by Trial Phase, Trial Status, Trial ...

Short Hills, New Jersey and Adelaide, South Australia--(Newsfile Corp. - April 14, 2023) - Humanigen, Inc. (Nasdaq: HGEN), Humanigen Australia Pty Ltd, (Humanigen) and the South Australian Health and ...

The researchers credit wider availability of molecular testing and better understanding of the diseases for the emerging targeted therapies in development. As ongoing studies continue to investigate ...

DEAR DR. ROACH: My husband recently passed away one week after his 80th birthday. According to his death certificate, he died of lung cancer (not a surprise) and chronic myelomonocytic leukemia (CMML) ...

Table 1 List of main genes whose recurrent mutation has been observed in CMML cells At some point, a lesion conferring a competitive advantage to the HSC can occur. Such ‘competitive advantage’ is ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...

Azacitidine is standard, first-line therapy in higher-risk myelodysplastic syndromes (MDS). Whether azacitidine-based combinations with lenalidomide or vorinostat produce superior overall response ...

Background: A 75-year-old female presented with a 1 month history of nonbloody diarrhea, associated with abdominal cramping and urgency. Her medical history was notable for chronic myelomonocytic ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage oncology company dedicated to the discovery and development of novel biotherapeutics by ...

Results of a phase 1/2 trial show encouraging outcomes for patients with higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) treated with the fully oral regimen of ...